Jan 3, 2023
VistaGen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, has recently filed national applications at the U.S. Patent and Trademark Office designed to provide additional patent protection for its lead product candidate, PH94B. The company has also filed similar applications with counterpart patent authorities in major pharmaceutical markets outside the United States. The filings are related to PH94B and the treatment of adjustment disorder (“AjD”). According to the company, these filings are a strategic “next step” in VistaGen’s ongoing efforts to enhance potential commercial protection across its CNS pipeline in key pharmaceutical marketsand provide global exclusivity platform for PH94B in AjD; the company is working to provide patent protection that is similar to that of its protection for PH94B for the treatment of social anxiety disorder (“SAD”) as well as its exclusive late-clinical stage product candidate, PH10, for the treatment of major depressive disorder (“MDD”). The company also noted that it is in the process of finalizing an acquisition of its acquisition of Pherin Pharmaceuticals Inc., which will include Pherin’s entire pherine pipeline as well as intellectual property rights to PH94B, a substance that is in phase 3 development for the treatment of SAD and phase 2 development for the treatment of AjD with anxiety (“AjDA”), and PH10, which is in clinical development for MDD. The acquisition will also give VistaGen full ownership of three new early clinical-stage pherine product candidates: PH15 for cognition improvement, PH284 for appetite-related disorders, and PH80 for migraine and hot flashes.
To view the full press release, visit https://ibn.fm/OVJEk
About VistaGen Therapeutics Inc.
VistaGen is a late clinical-stage CNS-focused biopharmaceutical aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster acting and with fewer side effects and safety concerns than those that are currently available. VistaGen’s clinical-stage candidates are targeting multiple types of anxiety and depression. PH94B and PH10 belong to a new class of drugs known as pherines, which are odorless and tasteless investigational neuroactive steroids designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can impact the olfactory-amygdala neural circuits without systemic uptake or direct activity on CNS neurons in the brain. VistaGen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety and depression — one mind at a time. For more information about the company, please visit www.VistaGen.com.
NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork
A little-known South Korean music act has climbed the charts with a viral hit that has caught listeners off guard – not just for its sudden popularity, but because its vocals were generated entirely by artificial intelligence. Meomuru’s single, “Have You Become the Adult You Dreamed Of?”, climbed to No 2 on Melon’s Top 100 – South Korea’s flagship streaming chart – earlier this week. The track’s popularity has turned Meomuru into one of the country’s most-talked-about acts. The song was created...
Southeast Asia’s electric vehicle boom risks leaving the region’s smaller companies behind, as Chinese automotive giants bypass local part-makers in favour of imported components and locked-in supplier networks. Local manufacturers across Indonesia, Thailand and Malaysia are facing a double squeeze: demand is weakening for parts used in petrol and diesel cars, collectively known as internal combustion engine (ICE) vehicles, while steep barriers to entry also keep them out of EV supply...
The theft of billions of dollars from Binance within a matter of minutes, the biggest cryptocurrency heist in history, was orchestrated by North Korean hackers, the FBI said on Saturday. The Federal Bureau of Investigation said in a statement that this week’s attack was tied to “malicious cyber activity” by an entity known as TraderTraitor, the same actors behind a US$1.5 billion Bybit hack last year. The FBI asked cryptocurrency exchanges, blockchain analytics companies and others to block...
This week’s $6.3 billion hack of Binance is the largest to hit crypto, and would be the most that North Koreans have stolen in years of brazen cybercrime.
Residents say a proposed Chinese car plant in northern Spain will create new jobs. Others say it’s a long-term risk, distilling a debate about the costs and perks of ties to China.
With US President Donald Trump recently pushing the use of “superintelligence” (SI) instead of artificial intelligence (AI) in national discourse, the acronym has gained unprecedented attention. It is the right acronym but the wrong meaning. In my opinion, SI should stand for “self-intelligence”. It probably explains why academics, critics and even major AI companies are calling for a temporary pause in AI development. They must have realised the technology’s current trajectory is headed down...
Nearly 200 nations have struck hard-fought agreements at a UN biodiversity summit, but the outcome was accompanied by disappointment over missed opportunities to address humanity’s destructive toll on nature. Delegates cheered on Friday as crucial texts were approved in overtime but the celebrations were tempered by acrimonious debates and regret over limited progress on some of the most contentious issues. The Cop17 summit in Armenia sought to revive a landmark commitment to halt and reverse...
Apple’s long-awaited artificial intelligence features will be officially launched in China in December, ending two years of regulatory uncertainty as the US tech giant seeks to bring advanced technologies to its second-largest market with the help of Alibaba Group Holding. The first batch of Apple Intelligence services will roll out to Chinese iPhone users alongside the iOS 27.3 update in December, following an open beta test with developers starting November 4, the US company said in a...
In the Land of the Rising Sun, Bangladesh looks forward to a new dawn. The hope that comes with Prime Minister Tarique Rahman’s visit to Japan goes beyond the deals signed or the financial support expected. It shows a country that has emerged from authoritarian rule and wants to turn its new political voice into bigger economic chances and freedom of choice. For a government chosen by the people, foreign policy must answer one question: how does it make life better for the people who gave it...
Contemporary Amperex Technology Ltd (CATL) has doubled down on new businesses including battery swapping and energy storage as the world’s largest battery maker seeks new growth drivers amid intensifying price wars and mounting pressure on profitability. But the new path is far from straightforward. Established players like Nio have already built a strong presence in battery swapping, while BYD has reinforced its position in energy-storage systems. Lucas Zhang Liutong, director of Hong...
The former vice premier was one of just six women to have served on the Chinese Communist Party’s elite Politburo, though she was excluded from the top ranks of power.
After spending three months in a coma following a brain haemorrhage, a patient in China has regained the ability to speak, eat and walk with support – part of an early clinical trial using targeted sound waves to help “wake up” severely damaged brains, according to state media. The technology, developed by a coalition including the Chinese Academy of Sciences’ Shenzhen Institutes of Advanced Technology, used focused ultrasound waves to stimulate regions deep within the brain without requiring...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.